Lin; Shuqun

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lin; Shuqun.The latest application filed is for "amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha responses".

Company Profile

5.20.19

Lin; Shuqun - Newtown PA
- Newtown PA US
Lin; Shuqun - Huntingdon Valley PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN.alpha. responses Grant RE47,929 - Moslin , et al.	2020-04-07
Amide-substituted Heterocyclic Compounds Useful As Modulators Of Il-12, Il-23 And/or Ifn Alpha Responses App 20200071315 - Moslin; Ryan M. ; et al.	2020-03-05
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Grant 10,526,321 - Wrobleski , et al. J	2020-01-07
Tricyclic heterocyclic compounds useful as inhibitors of TNF Grant 10,308,652 - Wrobleski , et al.	2019-06-04
Amide-substituted Heterocyclic Compounds Useful As Modulators Of Il-12, Il-23 And/or Ifn Alpha Responses App 20180265504 - Moslin; Ryan M. ; et al.	2018-09-20
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Grant 10,000,480 - Moslin , et al. June 19, 2	2018-06-19
Tricyclic Heterocyclic Compounds Useful As Inhibitors Of Tnf App 20180111937 - WROBLESKI; Stephen T. ; et al.	2018-04-26
Amide-substituted Heterocyclic Compounds Useful As Modulators Of Il-12, Il-23 And/or Ifn Alpha Responses App 20170022192 - Moslin; Ryan M. ; et al.	2017-01-26
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN.alpha. responses Grant 9,505,748 - Moslin , et al. November 29, 2	2016-11-29
Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFN.alpha. responses Grant 9,315,494 - Moslin , et al. April 19, 2	2016-04-19
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Grant 9,221,826 - Wrobleski , et al. December 29, 2	2015-12-29
Alkyl-amide-substituted Pyridyl Compounds Useful As Modulators Of Il-12, Il-23 And/or Ifn Alpha Responses App 20150307483 - Moslin; Ryan M. ; et al.	2015-10-29
Amide-substituted Heterocyclic Compounds Useful As Modulators Of Il-12, Il-23 And/or Ifn Alpha Responses App 20150299183 - Moslin; Ryan M. ; et al.	2015-10-22
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Grant 8,987,268 - Wrobleski , et al. March 24, 2	2015-03-24
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Grant 8,921,368 - Wrobleski , et al. December 30, 2	2014-12-30
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Grant 08921368 -	2014-12-30
Pyrrolopyridazine Jak3 Inhibitors And Their Use For The Treatment Of Inflammatory And Autoimmune Diseases App 20140011800 - Wrobleski; Stephen T. ; et al.	2014-01-09
Pyrrolopyridazine Jak3 Inhibitors And Their Use For The Treatment Of Inflammatory And Autoimmune Diseases App 20140011795 - Wrobleski; Stephen T. ; et al.	2014-01-09
Pyrrolopyridazine Jak3 Inhibitors And Their Use For The Treatment Of Inflammatory And Autoimmune Diseases App 20140005146 - Wrobleski; Stephen T. ; et al.	2014-01-02
Heterocyclic amide compounds useful as kinase inhibitors Grant 8,404,689 - Wrobleski , et al. March 26, 2	2013-03-26
Heterocyclic Amide Compounds Useful As Kinase Inhibitors App 20110160207 - Wrobleski; Stephen T. ; et al.	2011-06-30
Heterocyclic amide compounds useful as kinase inhibitors Grant 7,935,696 - Wrobleski , et al. May 3, 2	2011-05-03
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors Grant 7,923,556 - Wrobleski , et al. April 12, 2	2011-04-12
Fused heterocyclic compounds useful as kinase modulators Grant 7,723,336 - Vaccaro , et al. May 25, 2	2010-05-25
Phenyl-substituted Pyrimidine Compounds Useful As Kinase Inhibitors App 20100029649 - Wrobleski; Stephen T. ; et al.	2010-02-04
Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors Grant 7,642,257 - Das , et al. January 5, 2	2010-01-05
Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors Grant 7,419,978 - Das , et al. September 2, 2	2008-09-02
Heterocyclic Amide Compounds Useful As Kinase Inhibitors App 20080171741 - Wrobleski; Stephen T. ; et al.	2008-07-17
Phenyl-aniline Substituted Bicyclic Compounds Useful As Kinase Inhibitors App 20080167304 - Das; Jagabandhu ; et al.	2008-07-10
Fused Heterocyclic Compounds Useful As Kinase Modulators App 20080045536 - Vaccaro; Wayne ; et al.	2008-02-21
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors App 20060178388 - Wrobleski; Stephen T. ; et al.	2006-08-10
Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors App 20050143398 - Das, Jagabandhu ; et al.	2005-06-30
Compounds that inhibit the binding of integrins to their receptors Grant 6,262,084 - Biediger , et al. July 17, 2	2001-07-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.